Skip to main content
SpringerLink
Log in
Book cover

Advances in Breast Cancer Management pp 25–37Cite as

Sentinel Lymphadenectomy In Node Negative Breast Cancer

  • Chapter

Part of the book series: Cancer Treatment and Research ((CTAR,volume 103))

Abstract

Axillary lymphadenectomy (ALND) remains the gold standard for identifying axillary nodal metastases and managing patients with early stage breast cancer.1 A level I and II ALND accurately stages the patient, allowing for prognostication and decisions regarding adjuvant therapy. Furthermore, excellent regional control is achieved with ALND, with subsequent axillary recurrence a rare event.2,3 There may be an improvement in survival after ALND, however, this remains debatable. As the use of screening mammography increases, the size of primary breast cancers has been progressively diminishing over the last few decades, concomitant with a declining proportion of patients who have axillary metastases.4

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. National Institutes of Health. NIH consensus conference on the treatment of early-stage breast cancer. JAMA 265: 391–395, 1991.

    Article  Google Scholar 

  2. Halverson KJ, Taylor ME, Perez CA, et al. Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer. Int J Radiat Oncol Biol Phys 26: 593–599, 1993.

    Article  PubMed  CAS  Google Scholar 

  3. Recht A, Pierce SM, Abner A, et al. Regional node failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 9: 988–996, 1991.

    PubMed  CAS  Google Scholar 

  4. Cady B, Stone MD, Schuler JG, et al. The new era in breast cancer: invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 131: 301–308, 1996.

    Article  PubMed  CAS  Google Scholar 

  5. Keramopoulos A, Tsionou C, Minaretzis D, et al. Arm morbidity following treatment of breast cancer with total axillary dissection: A multivariated approach. Oncology 50: 445–449, 1993.

    Article  PubMed  CAS  Google Scholar 

  6. Ivens D, Hoe AL, Podd TJ, et al. Assessment of morbidity from complete axillary dissection. Br J Cancer 66: 136–138, 1992.

    Article  PubMed  CAS  Google Scholar 

  7. Larson D, Weinstein M, Goldberg I, et al. Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys 12: 1575–1582, 1986.

    Article  PubMed  CAS  Google Scholar 

  8. Early Breast Cancer Trialists’ Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 339: 1–15, 1992.

    Google Scholar 

  9. Early Breast Cancer Trialists’ Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 339: 71–85, 1992.

    Google Scholar 

  10. Silverstein MJ, Gierson ED, Waisman JR, et al. Axillary lymph node dissection for T1a breast carcinoma. Is it indicated? Cancer 73: 664–667, 1994.

    Article  PubMed  CAS  Google Scholar 

  11. Jamali FR, Kurtzman SH, Deckers PJ. Role of axillary dissection in mammographically detected breast cancer. Surg Oncol Clin Nor Am 6: 343–358, 1997.

    CAS  Google Scholar 

  12. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127: 392–399, 1992.

    Article  PubMed  CAS  Google Scholar 

  13. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220: 391–401, 1994.

    Article  PubMed  CAS  Google Scholar 

  14. Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15: 2345–2350, 1997.

    PubMed  CAS  Google Scholar 

  15. Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222: 394–401, 1995.

    Article  PubMed  CAS  Google Scholar 

  16. Turner RR, O11ila DW, Krasne DL, et al. Histopathological validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 226: 271–278, 1997.

    Article  PubMed  CAS  Google Scholar 

  17. Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 227: 645–653, 1998.

    Article  PubMed  CAS  Google Scholar 

  18. Guenther JM, Krishnamoorthy M, Tan LR. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am 3: 336–340, 1997.

    PubMed  CAS  Google Scholar 

  19. Koller M, Barsuk D, Zippel D, et al. Sentinel lymph node involvement: a predictor for axillary node status with breast cancer — has the time come? Eur J Surg Oncol 24: 166–168, 1998.

    Article  PubMed  CAS  Google Scholar 

  20. Flett MM, Going JJ, Stanton PD et al. Sentinel node localization in patients with breast cancer. Br J Surg 85: 991–993, 1998.

    Article  PubMed  CAS  Google Scholar 

  21. Dale PS, Williams JT, IV. Axillary staging utilizing selective sentinel lymphadenectomy for patients with invasive breast carcinoma. Am Surg 64: 28–32, 1998.

    PubMed  CAS  Google Scholar 

  22. Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2: 335–339, 1993.

    Article  PubMed  CAS  Google Scholar 

  23. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349: 1864–1867, 1997.

    Article  PubMed  CAS  Google Scholar 

  24. Pijpers R, Meijer S, Hoekstra OS, et al. Impact of lymphoscintigraphy on sentinel node identification with Technetium-99m-colloidal albumin in breast cancer. J Nucl Med 38: 366–368, 1997.

    PubMed  CAS  Google Scholar 

  25. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer. NEJM 339: 941–946, 1998.

    Article  PubMed  CAS  Google Scholar 

  26. Borgstein PJ, Pijpers R, Comans EF, et al. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 186: 275–283, 1998.

    Article  PubMed  CAS  Google Scholar 

  27. Crossin JA, Johnson AC, Stewart PB, et al. Gamma-probe-guided resection of the sentinel lymph node in breast cancer. Am Surg 64: 666–669, 1998.

    PubMed  CAS  Google Scholar 

  28. Miner TJ, Shriver CD, Jaques DP, et al. Ultrasonographically guided injection improves localization of the radiolabeled sentinel lymph node in breast cancer. Ann Surg Oncol 5: 315–321, 1998.

    Article  PubMed  CAS  Google Scholar 

  29. Offodile R, Hoh C, Barsky SH, et al. Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran. Cancer 82: 1704–8, 1998.

    Article  PubMed  CAS  Google Scholar 

  30. De Cicco C, Cremonesi M, Luini A, et al. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer J Nucl Med 12: 2080–4, 1998.

    Google Scholar 

  31. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276: 1818–1822, 1996.

    Article  PubMed  CAS  Google Scholar 

  32. Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identify sentinel lymphnode in breast cancer. Lancet 349: 1668–1669, 1997.

    Article  PubMed  CAS  Google Scholar 

  33. O’Hea BJ, Hill ADK, El-Shirbiny AM, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 186: 423–427, 1998.

    Article  PubMed  Google Scholar 

  34. Barnwell JM, Arredondo MA, Kollmorgen D, et al. Sentinel node biopsy in breast cancer. Ann Surg Oncol 5: 126–130, 1998.

    Article  PubMed  CAS  Google Scholar 

  35. Liberman L, Vuolo M, Dershaw DD et al. Epithelial displacement after stereotactic 11-gauge directional vacuum-assisted breast biopsy. AJR 172: 677–81, 1999.

    PubMed  CAS  Google Scholar 

  36. Glass EC, Essner R, Giuliano AE. Sentinel node localization in breast cancer. Sem Nuc Med 24: 57–68, 1999.

    Google Scholar 

  37. Glass EC, Basinski JE, Krasne DL, Giuliano AE. Radiation safety considerations for sentinel node techniques. Ann Surg Oncol 6: 10–1, 1999.

    Article  PubMed  CAS  Google Scholar 

  38. Larsen VH, Freundendal-Pedersen A, Fogh-Andersen N. The influence of Patent Blue V on pulse oximetry and haemoximetry. Acta Anaes Scand 39 (Suppl 107): 53–55, 1995.

    Article  Google Scholar 

  39. Hirsch JI, Tisnado J, Cho S-R et al. Use of isosulfan blue for identification of lymphatic vessels: experimental and clinical evaluation. AJR 139: 1061–1064, 1982.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Surgical Oncology, John Wayne Cancer Institute, USA

    Philip I. Haigh M.D., FRCS(C) (Clinical Fellow)

  2. Saint John’s Health Center, John Wayne Cancer Institute, USA

    Armando E. Giuliano M.D. (Chief of Surgical Oncology,Clinical Professor of Surgery)

  3. UCLA School of Medicine, USA

    Armando E. Giuliano M.D. (Chief of Surgical Oncology,Clinical Professor of Surgery)

Authors
  1. Philip I. Haigh M.D., FRCS(C)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Armando E. Giuliano M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Breast Medical Oncology, Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Medical School, 676 North St. Clair Street, Suite 850, 60611-2927, Chicago, IL, USA

    William J. Gradishar M.D. (Associate Professor of Medicine, Director) (Associate Professor of Medicine, Director)

  2. Cancer Center, Department of Surgery, Emory University School of Medicine, 1364 Clifton Road, N.E., Suite B206, 30322-1104, Atlanta, GA, USA

    William C. Wood M.D. (Joseph Brown Whitehead Professor and Chairman, Clinical Director) (Joseph Brown Whitehead Professor and Chairman, Clinical Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media New York

About this chapter

Cite this chapter

Haigh, P.I., Giuliano, A.E. (2000). Sentinel Lymphadenectomy In Node Negative Breast Cancer. In: Gradishar, W.J., Wood, W.C. (eds) Advances in Breast Cancer Management. Cancer Treatment and Research, vol 103. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-3147-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-3147-7_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-3149-1

  • Online ISBN: 978-1-4757-3147-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation